Recently, Glaxo SmithKline reported that they will no longer seek approval to sell Avodart as a preventive for prostate cancer. According to The Philadelphia Inquirer the drug cannot be used for prostate-tumor reduction because a study showed that patients developed dangerous forms of prostate cancer.
GSK announced on March 23 that it will no longer pursue global approval for the use of Avodart to prevent prostate cancer and will work with regulatory agencies to remove the indication from the label. They will also help doctors to communicate with their patients about the drug.
The study that was done by the New England Journal of Medicine said that patients using the drug developed dangerous forms of prostate cancer within four years. If you were taking Avodart and experienced serious side effects, you would be advised to contact an experienced medical malpractice attorney.
Cherry Injury Law have the experience and knowledge needed to represent clients involved in even the most complex dangerous drugs cases. They will review all of the facts of your case to determine negligence and the extent of your injuries. Deadly drug cases occur when a drug with dangerous side effects makes it to the market without these effects coming to light during clinical trials. Call today if you or a loved one suffered an injury resulting from the use of a dangerous drug.